Marsh & McLennan (NYSE: MMC) CEO receives major stock awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Marsh & McLennan Companies President and CEO John Q. Doyle reported two equity awards. He acquired 217,501 stock options on February 24, 2026 at a grant price of $0.00 per option. These options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
He also acquired 59,510 restricted stock units on February 24, 2026. These RSUs relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both instruments convert into common stock on a 1-for-1 basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Doyle John Q
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 217,501 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 59,510 | $0.00 | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 217,501 shares (Direct);
Restricted Stock Units — 59,510 shares (Direct)
Footnotes (1)
- These options were granted on February 24, 2026 and vest in four equal annual installments on February 24th of 2027, 2028, 2029 and 2030. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis. These restricted stock units relate to performance stock units that were granted on February 23, 2023 for the performance period 2023-2025. The performance factor for these performance stock units was determined on February 24, 2026. Not applicable.
FAQ
What insider transactions did MMC CEO John Q. Doyle report on this Form 4?
John Q. Doyle reported two equity awards: 217,501 stock options and 59,510 restricted stock units, both acquired on February 24, 2026. The filing classifies each as a grant or other acquisition transaction, rather than an open-market purchase or sale of Marsh & McLennan common stock.
How many stock options were granted to MMC CEO John Q. Doyle and how do they vest?
John Q. Doyle was granted 217,501 stock options on February 24, 2026 at a stated price of $0.00 per option. These options vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030, according to the transaction footnote.
What restricted stock units did MMC CEO John Q. Doyle receive in this filing?
He acquired 59,510 restricted stock units on February 24, 2026. The RSUs relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor for those performance stock units determined on February 24, 2026.
What is the conversion ratio for John Q. Doyle’s stock options and RSUs at Marsh & McLennan (MMC)?
The filing states that the security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis. This means each option or restricted stock unit corresponds to one share of common stock upon conversion, based on the terms described in the footnotes.
Are John Q. Doyle’s reported awards in this MMC Form 4 direct or indirect holdings?
Both the 217,501 stock options and 59,510 restricted stock units are reported as directly owned. The transaction records list the ownership type and code as direct, and no footnotes indicate that the awards are held through a separate entity or indirect arrangement.
What performance period underlies the MMC restricted stock units reported for John Q. Doyle?
The restricted stock units reported relate to performance stock units granted on February 23, 2023, covering the 2023–2025 performance period. The performance factor for these performance stock units, which determines the RSU outcome, was set on February 24, 2026, according to the disclosure footnote.